Αποτελέσματα Αναζήτησης
1 Ιουλ 2020 · Dr. Aditya Bardia: A 62-year-old woman was evaluated at this hospital after she had identified a mass in her left breast, confirmed by her physician on physical examination, during the pandemic of...
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Evolution and prognostic significance of HER-2 conversion...
- 20-Year Risks of Breast-Cancer Recurrence After Stopping Endocrine Therapy at 5 Years
During the study period from 5 to 20 years, the absolute...
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Prediction of Oncotype DX Recurrence Score Based on...
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
The RASTER (Microarray Prognostics in Breast Cancer) study...
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal publishing oncology case reports. It aims to share awareness of groundbreaking cases that give insight into redefining concepts in cancer.
5 Απρ 2011 · Eleven years disease-free: role of chemotherapy in metastatic BRCA2 -related breast cancer. Lasting complete remission from widespread bone metastases is rare. The case of a 41-year-old ...
5 Ιουν 2024 · A 45-year-old woman was evaluated in the oncology clinic of the hospital because of metastatic triple-negative breast cancer that had progressed despite chemotherapy. Management decisions were...
25 Σεπ 2019 · Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain. Authors: Timothy E. Guiney, M.D., Mathew S. Lopes, M.D., Mannudeep K. Kalra, M.D., Meghan J. Mooradian, M.D., Tomas G. Neilan,...
20 Σεπ 2024 · Recurrent Cutaneous Manifestation in Multiple Myeloma. Mariam Hina, Saad Salim Naviwala, Munira Shabbir-Moosajee, Nasir Ali. 6 August 2024. Resolution of a chronic occipital wound with exposed skull bone with a fish skin graft: a successful treatment approach.
28 Μαΐ 2021 · Most prevalent cancers were skin (28%), breast (15%), and prostate (15%). Compared to controls, cancer cases who had survived in 1-5 years reported higher rates of poor general health (38% vs. 27%, p <.0001), hospitalizations (31% vs. 17%, p <.0001), mental health visits (9% vs. 7%, p =.0204).